Prosecution Insights
Last updated: November 04, 2026
Application No. 17/126,660

ENDOCYTE CANNULA

Non-Final OA §102§103
Filed
Dec 18, 2020
Priority
Feb 11, 2014 — provisional 61/938,377 +3 more
Examiner
DOUGHERTY, SEAN PATRICK
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
All Cape Gynecology LLC
OA Round
5 (Non-Final)
74%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
726 granted / 975 resolved
+4.5% vs TC avg
Strong +16% interview lift
Without
With
+16.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
54 currently pending
Career history
1042
Total Applications
across all art units

Statute-Specific Performance

§101
8.5%
-31.5% vs TC avg
§103
35.1%
-4.9% vs TC avg
§102
27.9%
-12.1% vs TC avg
§112
25.0%
-15.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 975 resolved cases

Office Action

§102 §103
DETAILED ACTION Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 3/13/2026 has been entered. Response to Arguments Applicant's arguments filed 3/13/2026 have been fully considered but they are not persuasive. Applicant argues that Kohl’s pipette is slidably engaged in the sheath and extends from or retracts into the sheath, which is not an interchangeable scraping attachment removably received on the distal end of the tubular body. Examiner disagrees and submits that Kohl’s pipette 12 is removable from sheath 4, so sheath 4 including spatula 32 is removably received on the distal end of tube 48 and, being separable, is capable of being interchanged. The claims do not exclude the tubular body sliding through the attachment. Claim 8 itself recites the distal end extending through the entire length of the attachment and out of the second opening, as in Kohl. Applicant argues that bore 40 is described in the context of the sheath through which the pipette slides, and not as a receiving passage of a separate attachment. Examiner disagrees and submits that bore 40 extends through the spatula 32 and nose 34 and receives the distal end of tube therethrough to opening 38, which is all the claimed receiving passage requires. Applicant argues that Kohl does not disclose an attachment configured to provide mechanical scraping or brushing and to collect and retrieve the sampled material. Examiner disagrees and submits that Kohl’s spatula sampling tip 8 is rotated against the tissue sample to sample the portio vaginalis and is employed to sample the endocervical canal. Kohl’s structure is fully capable of performing the claimed functions. Flat spatula 32 and nose 34 scrape tissues as the sheath is rotated, and the loosened cells are collected through opening 38 and bore 40 into tube 48 under suction and retrieved with the pipette. When the prior art structure is the same as claimed, it is capable of performing the claimed function. The rejections are maintained. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 8, 9, 13, 16, 17, 30 and 34 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 3,796,211 to Kohl. Regarding Claims 1 and 30, Kohl discloses a medical device comprising inter alia: a tubular body (pipette 12 including plastic tube 48) having a proximal end (col. 3, lines 43-44 “The tube projects forwardly from the distal end 50 of the barrel…”) and a distal end (col. 3, lines 44-45 “…terminates at the proximal end 51…”), wherein the tubular body is rigid (col. 3, line 42 “…"memory" capability…”) and comprises a hollow channel (through plastic tube 48 to pipette 12, col. 3, lines 60-61 “…specimen is then withdrawn into the pipette… ); an interchangeable scraping attachment (sheath 4 including spatula 32) removably received on the distal end of the tubular body (col. 3, lines 8-10 “The pipette 12 is also removable from the sheath at the proximal end 18 thereof…”; the sheath is capable of being removed/interchanged), the scraping attachment comprising a receiving passage (cylindrical bore 40) configured to receive at least a portion of the distal end of the tubular body therethrough (col. 3, lines 31-33 “a smooth cylindrical bore 40 which extends forwardly from the nipple 30 through the spatula 32 and the nose 34”; see FIG. 3), wherein the distal end and the scraping attachment are configured to be received into body cavity/endocervical canal (col. 3, lines 3-8 “…an aspirator tube or pipette 12 which is slidably engaged in the sheath, to be extended from the tip 8 into the endocervical canal 14 and/or uterine cavity of the patient, or alternately to be retracted into sheath 4 from the canal, while the tip 8 is engaged with the cervix.”) (col. 2, col. 4 “…spatula sampling tip…”) (col. 2, line 67 to col. 3, line 2 “…spatulated sampling tip 8 … adapted to engage the cervix 10 of the patient…”) and wherein the scraping attachment has a planar wing that extends laterally relative to/from the tubular body (col. 3, lines 25-26 “…tip 8 comprises a flat, generally heart-shaped spatula 32…”), the scraping attachment configured to provide mechanical scraping or brushing in the body cavity/endocervical canal and to collect and receive a cellular specimen/cells from the endocervical canal and to collect and retrieve a cellular specimen (Kohn claim 18 “spatulated sampling tip, and the sheath is rotated to sample the portio vaginalis”) (col. 4, lines 3-7 “the device may also be employed to sample the endocervical canal, and/or the portio vaginalis”) (col. 3, lines 52-55 “the tip is abutted against the portio vaginalis of the cervix, with the nose 34 of the same protruding into the endocervical canal 14”, where rotating sheath 4 per Kohl claim 18 rotated nose 34 against the wall of the canal) an aspiration device received on/included on the proximal end wherein the aspiration device interfaces with the tubular body to create a force through the tubular body (col. 3, lines 47-48 “The coupling 52 is threaded for attachment to an aspirator (not shown)…”). Regarding Claims 8 and 9, Kohl discloses the medical device of claim 1, wherein the receiving passage (cylindrical bore 40) extends through an entire length of the scraping attachment, having a first opening on a first end and a second opening on a second end, and wherein the distal end of the tubular body extends into the first opening, through the length of the scraping attachment, and at least a portion of the distal end of the tubular body extends out of the second opening when the scraping attachment is attached to the tubular body where at least one aperture is located on a portion of the distal end that extends through the scraping attachment and a second opening when the scraping attachment is attached to the tubular body (col. 3, lines 31-33 “…a smooth cylindrical bore 40 which extends forwardly from the nipple 30 through the spatula 32 and the nose 34…”) (see FIG. 3) (col. 3, lines 3-8 “…an aspirator tube or pipette 12 which is slidably engaged in the sheath, to be extended from the tip 8 into the endocervical canal 14 and/or uterine cavity Hi of the patient, or alternately to be retracted into sheath 4 from the canal, while the tip 8 is engaged with the cervix.”). Regarding Claim 13, Kohl discloses the medical device of claim 1, wherein the tubular body is configured to aspirate bodily tissues (col. 4, lines 3-7 “… all four quadrants of the cavity are sampled in this fashion, and if desired, the device may also be employed to sample the endocervical canal, and/or the portio vaginalis…”). Regarding Claim 16, Kohl discloses the medical device of claim 1, wherein the body cavity is an endocervical canal (col. 4, lines 3-7 “… all four quadrants of the cavity are sampled in this fashion, and if desired, the device may also be employed to sample the endocervical canal, and/or the portio vaginalis…”). Regarding Claim 17, Kohl discloses the medical device of claim 1, wherein the tubular body comprises plastic (plastic tube 48). Regarding Claim 34, Kohl discloses the medical device of claim 1, wherein the medical device is configured to perform a Papanicolau test (the device of Kohl is capable of being used to perform a Papanicolau test because Kohl is an aspirating cervical sampling that collects cellular material and would allow one to discharge a specimen onto a repository). Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 5 and 6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kohl in view of US Patent No. 6,086,546 to Morris et al. (hereinafter, Morris). Kohl discloses the medical device of claim 1 as set forth and cited above, and further discloses where the distal end of the tubular body further comprises at least one aperture at the distal end fluidly connected to the hollow channel of the distal end of tubular body (col. 5, lines 12-14 “…opening in said distal end of the tube…”) when the scraping attachment is attached to the tubular body (FIG. 1) Kohl does not expressly disclose where the aperture has a first opening through an outer wall of the distal end tubular body and a second opening through an inner wall and fluidly connected to the hollow channel of the distal end of tubular body (Examiner notes such limitation is essentially claiming side/lateral apertures in the tubular body) when the scraping attachment is attached to the tubular body. However, Morris teaches an endometrial sampler that has an opening through an outer wall of the distal end of the tubular body (opening 12) and also includes two further side/lateral openings (side openings 13 and 14) (col. 2, lines 1-9) (FIG. 3). One having an ordinary skill in the art at the time the invention was filed would have found it obvious to modify the distal end of the tubular body and opening in the distal end of the tube of Kohl to also include the side/lateral apertures in the tubular body as set forth in Morris, as Morris teaches that the addition of the side/lateral openings would have increased the effectiveness in loosing cells and would also helped reduce the damage to the cells (col. 3, lines 19-31). Such modification would also yield side/lateral apertures when the scraping attachment is attached to the tubular body. Claim(s) 10, 11, 27 and 31 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kohl in view of US 4620548 A to Hasselbrack. Kohl discloses the medical device of claim 1 as set forth and cited above and/or discloses all the limitations in Claim 27 (except for the following), including where the scraping attachment is configured to be received into an endocervical canal and is configured to provide mechanical scraping or brushing in the endocervical canal to collect cells from the endocervical canal (see the rejection of claim 30 above). Kohl does not expressly disclose wherein the aspiration device is a syringe or wherein aspiration device is a depressible bulb configured to be squeezed, and wherein the force through the tubular body is suction. However, Hasselbrack teaches an endocervical sampling device that includes collecting cells via a squeeze bulb or a syringe (Abstract). One having an ordinary skill in the art at the time the invention was filed would have found it obvious to modify the aspiration device of Kohl to interface with the squeeze bulb or syringe of Hasselbrack as Hasselbrack teaches at col. 6, line 63 to col. 7, line 7 that such devices would have concentrated suction in the endocervical canal for collection of cells. Claim(s) 28 and 29 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kohl in view of Hasselbrack and further in view of US Patent No. 6,086,546 to Morris et al. (hereinafter, Morris). Kohl in view of Hasselbrack teach where the scraping attachment comprises a planar wing extending laterally from the tubular body (Kohl: col. 3, lines 25-26 “…tip 8 comprises a flat, generally heart-shaped spatula 32…”). Kohl in view of Hasselbrack do not expressly teach wherein the distal end comprises at least one aperture, the at least one aperture having a first opening through an outer wall of the distal end and a second opening through an inner wall of the hollow channel of the tubular body. However, Morris teaches an endometrial sampler that has an opening through an outer wall of the distal end of the tubular body (opening 12) and also includes two further side/lateral openings (side openings 13 and 14) (col. 2, lines 1-9) (FIG. 3). One having an ordinary skill in the art at the time the invention was filed would have found it obvious to modify the distal end of the tubular body and opening in the distal end of the tube of Kohl to also include the side/lateral apertures in the tubular body as set forth in Morris, as Morris teaches that the addition of the side/lateral openings would have increased the effectiveness in loosing cells and would also helped reduce the damage to the cells (col. 3, lines 19-31). Such modification would also yield side/lateral apertures when the scraping attachment is attached to the tubular body. Claim(s) 32 and 33 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kohl in view of US 20120289858 A1 to Ouyang et al. (hereinafter, Ouyang). Kohl discloses the medical device of claim 1. Kohl does not expressly disclose a light source and a camera. However, Ouyang teaches an integrated apparatus for examining uterine tissues ([0033]) which includes a light source (illuminated device A108B, paragraph [0159]) and a camera (imaging module A108, paragraph [0159]). One having an ordinary skill in the art at the time the invention was filed would have found it obvious to modify the device of Kohl to include the light source and camera of Ouyang as Ouyang teaches at paragraph [0034] that this would have improved diagnostic accuracy and at paragraph [0037] states this would have improved visual inspect and reduced debris. Claim(s) 35 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kohl in view of US 20160331357 A1 to Czarnecki et al. (hereinafter, Czarnecki) Regarding Claim 35, Kohl discloses the medical device of claim 1. Kohl does not expressly disclose wherein the medical device is substantially 12 centimeter in total length as measured from the proximal end to the distal end. However, Czarnecki teaches a sample collection device that is a total of 12 centimeters in length (paragraph [0099]. One having an ordinary skill in the art at the time the invention was filed would have found it obvious to modify the device of Kohl to be the 12 centimeters in length as Czarnecki teaches at paragraph [0099] that the length of a sample collection device can vary or be chosen based upon a desired sample collection area. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEAN PATRICK DOUGHERTY whose telephone number is (571)270-5044. The examiner can normally be reached 8am-5pm (Pacific Time). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jacqueline Cheng can be reached at (571)272-5596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SEAN P DOUGHERTY/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 7 earlier events
Jul 07, 2025
Interview Requested
Jul 30, 2025
Applicant Interview (Telephonic)
Jul 30, 2025
Examiner Interview Summary
Aug 11, 2025
Response Filed
Oct 14, 2025
Final Rejection mailed — §102, §103
Mar 13, 2026
Request for Continued Examination
Apr 02, 2026
Response after Non-Final Action
Oct 27, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778510
EAR-WEARABLE ELECTRONIC DEVICE INCLUDING IN-EAR OPTICAL HEART RATE AND BLOOD OXYGEN SATURATION SENSOR
4y 0m to grant Granted Nov 03, 2026
Patent 12765810
HIGHLY INTEGRATED ANALYTE DETECTION DEVICE
2y 11m to grant Granted Oct 20, 2026
Patent 12746369
GUIDE WIRE ACTIVATION MECHANISM AND PROXIMAL ACTUATION MECHANISM
3y 6m to grant Granted Sep 29, 2026
Patent 12746370
GUIDEWIRE HAVING RADIOPAQUE INNER COIL
3y 0m to grant Granted Sep 29, 2026
Patent 12740707
CALIBRATION UNIT FOR A MACROSCOPIC MEDICAL IMAGING DEVICE, MACROSCOPIC MEDICAL IMAGING CALIBRATION SYSTEM AND USE OF A CALIBRATION UNIT
3y 2m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
74%
Grant Probability
91%
With Interview (+16.2%)
3y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 975 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month